House legislators set to markup legislation related to rare diseases, pediatric oncology and HCT/Ps
The House of Representative’s Energy and Commerce Committee is set to convene this week for a markup hearing of 23 pieces of legislation, including four bills related to priority review vouchers, pediatric oncology drug testing requirements, cellular and tissue therapies, and orphan drug exclusivity eligibility. AgencyIQ has an explainer of all four bills and what you need to know.
Fill out the form to read the full article.
Required *